Institutional investors purchased a net $94.8 thousand shares of BIOS during the quarter ended March 2016 and now own 87.50% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Managed Health Care industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WYNNEFIELD CAPITAL, INC. Bought 725.0 Thousand shares of BioScrip Inc
MILLRACE ASSET GROUP, INC. Bought 654.6 Thousand shares of BioScrip Inc
ARDSLEY ADVISORY PARTNERS Bought 585.0 Thousand shares of BioScrip Inc